Abstract B080: A porcine model of pancreatic ductal adenocarcinoma for human scale translational cancer research
Authors: Laura Beltrán Sangüesa, Daniela Kalla, Katja Steiger, Dieter Saur, Krzysztof Flisikowski, Angelika Schnieke, Tatiana Flisikowska
Journal: Cancer Research (2024)

Abstract Pancreatic ductal adenocarcinoma (PDAC) remains a highly fatal form of cancer, requiring urgent advancements in diagnostic and therapeutic strategies. Although PDAC mouse models have been crucial in advancing our comprehension of the disease, they present some limitations in replicating key human PDAC aspects. In this study, we present the development of the first large animal model of pancreatic cancer via Cre activatable mutations in the endogenous KRAS and TP53 genes 1,2. In order to activate these mutations in the pancreas, two Cre driver pig lines expressing Cre recombinase from PTF1A 3 and PDX1 were created. Crossing both Cre lines with pigs carrying latent KRAS G12D and TP53 R167H alleles produced double (KC) and triple (KPC) genetically modified animals. Pathological analyses revealed the presence of inter- and intralobular fibrosis with multifocal acinar-to-ductal metaplasia (ADM), some low-grade PanINs, dysplasia, inflammation and duct obstruction in most of the KPC pigs between 3 to 6 months of age. Interestingly, the majority of these pigs already exhibited local metastasis in the lymph nodes, suggesting that the metastatic potential is established early in the tumorigenic process. Age-matched KC pigs exhibited mainly ADM with dysplasia. Flow cytometry and RNA expression analyses of the established pancreatic tumour primary cells revealed a pronounced epithelial-to-mesenchymal transition (EMT). Moreover, both bulk tumour samples and primary tumour cells showed high expression of the pancreatic cancer stem cell marker CD44, with differential expression of its isoforms, including the major isoform and variants 6 and 9. In addition, histological and molecular analyses revealed notable similarities between pig and human PDAC, including molecular subtypes, neuronal invasion and loss of acinar identity. These findings highlight the unique advantage of the pig PDAC model, that allows longitudinal and multi-regional tumour sampling in the absence of any therapeutic interventions. This makes it a valuable tool for developing new diagnostic and therapeutic approaches that can greatly improve patient outcomes in the long run. References1. Leuchs, S. et al. Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One 7, (2012). 2. Li, S. et al. Viable pigs with a conditionally- activated oncogenic KRAS mutation. Transgenic Res 24, 509–517 (2015). 3. Kalla, D. et al. The Missing Link: Cre Pigs for Cancer Research. doi:10.3389/fonc.2021.755746. Citation Format: Laura Beltrán Sangüesa, Daniela Kalla, Katja Steiger, Dieter Saur, Krzysztof Flisikowski, Angelika Schnieke, Tatiana Flisikowska. A porcine model of pancreatic ductal adenocarcinoma for human scale translational cancer research [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr B080.